MH-ART vs CF-IMRT in Postoperative Cervical/Endometrial Cancer
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This is an investigator-initiated, prospective, national multi-center, phase III, randomized, open-label, non-inferiority clinical study. The hypothesis is that using online adaptive radiotherapy technology for moderately fractionated radiotherapy in post-operative patients with cervical/endometrial cancer may reduce radiotherapy-related toxicity and improve quality of life while ensuring target coverage. The objective is to evaluate treatment-related toxicity and efficacy of moderately fractionated online adaptive radiotherapy compared to conventionally fractionated intensity-modulated radiotherapy in post-operative cervical and endometrial cancer patients, aiming to provide a more precise, convenient, and cost-effective treatment option for patients.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18-75 lat
- •Dobry stan ogólny, zdolność do leżenia przez 30 minut
- •Operacja raka szyjki macicy (całkowite usunięcie macicy z usuniętymi węzłami chłonnymi) lub endometrium
- •Rak szyjki macicy: wykryty w badaniu histologicznym z co najmniej jednym czynnikiem ryzyka (przerzuty do węzłów, dodatnie marginesy, naciek parametrium lub duży guz)
- •Rak endometrium: odpowiedni stopień zaawansowania i cechy histopatologiczne wymagające radioterapii
- •Dobrowolna zgoda i zdolność do świadomego wyboru udziału w badaniu
- •Niektórzy pacjenci mogą otrzymać dodatkową wewnętrzną radioterapię pochwy
- •Pacjenci z rakiem szyjki macicy muszą otrzymać chemioterapię równoczesnie z radioterapią
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 75 Years
- Last updated (source)
- September 16, 2026
- Sex
- Female only
Therapies / drugs in trial
Locations (1)
Peking Union Medical College Hospital
Beijing, China
Trial contact
Xiaorong Hou, Professor
Zihan Yan
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/17/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.